SIO and OncoDaily Announce Strategic Partnership to Advance Integrative Oncology Worldwide

OncoDaily

mRNA COVID-19 Vaccines Reprogram Tumor Immunity and Enhance Response to Checkpoint Inhibitors

mRNA COVID-19 Vaccines Reprogram Tumor Immunity and Enhance Response to Checkpoint Inhibitors

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Matt Sherer: Let's Talk Real Parity in Healthcare Payment

Matt Sherer

Cyprus Oncology Leaps Forward with New Larnaca Center

cyprus oncology

UICC Works to Improve Breast Cancer Outcomes in LMICs

Breast Cancer

Kimryn Rathmell: Understanding the 'Why, How, When, and Where' of Cancer in Rural Communities

Kimryn Rathmell

Susie Stanway: Looking Forward to Impactful Discussions at the China Anti Cancer Association's CCHIO

China Anti Cancer Association

OncoCalendar

Loading Events

« All Events

ESMO Advanced Course on Pancreatic Cancer

Nov 7 - Nov 8
ESMO

The ESMO Advanced Course on Pancreatic Cancer: From Standard Treatment to Individualization 2025 is a specialized two-day event scheduled to take place in Zurich, Switzerland, from November 7–8, 2025. The course is designed to provide oncology professionals with an updated, interdisciplinary overview of managing pancreatic cancer. A core goal is to move beyond generalized standards of care by interactively discussing treatment strategies based on patient cases, study data, and the latest ESMO Clinical Practice Guidelines. The course will challenge attendees to “think outside the box” regarding current and future individualized therapy strategies.

The program aims to address the most critical issues in an interdisciplinary way, ensuring participants can apply the information to individual clinical decision-making immediately upon returning to their practice. While the application deadline has closed, confirming the participant list is finalized, the course remains accredited with 9 ESMO-MORA category 1 points for medical oncologists seeking recertification. Non-local participants will be eligible for a travel grant of up to 600 euros to assist with their travel costs to the Zurich venue.

You can find more posts featuring ESMO on OncoDaily.